|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 00912515.4 (espacenet) (Federated) (European Patent Register), 20000228 | | Patent/reg. no. and date | DK/EP 1156856, 20050831 | | Publication date | 20011128 | | Priority no. and date | US 259910, 19990301, US 259911, 19990301 | | EP pub. no. and date |
EP 1156856 20011128 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 123920 | | Inventor | SCHMUTZ, Markus, Baumgartenweg 24
CH-4124 Schönenbuch, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4192 (2006.01) , A61P 25/00 (2006.01) | | Title | Anvendelse af fluorerede triazoler til behandling af neuropatisk smerte | | Int. application no. | EP2000001626 | | Int. publication no. | WO2000051577 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
